Exhibit 99.1

 

For more information, contact:

Investors:

Corey Kinger

corey.kinger@ww.com

Media:

Kelsey Merkel

kelsey.merkel@ww.com

WW International, Inc. Announces Third Quarter 2023 Results

 

●

End of Period Subscribers of 4.0 million

 

●

Revenues of $214.9 million

 

●

Gross margin of 66.0%; excluding the net impact of restructuring charges, adjusted gross margin of 66.2%

 

●

Operating Income of $30.6 million; excluding the net impact of restructuring charges, adjusted operating income of $36.6 million

 

●

Full Year Fiscal 2023 Guidance Update:

 

¡

Revenues are expected to be at the low end of the previously provided range of $890.0 million to $910.0 million

 

¡

Operating Income is now expected to be in the range of $31.0 million to $43.0 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income is still expected to be towards the high end of the previously provided range of $80.0 million to $85.0 million

NEW YORK (November 2, 2023) – WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the third quarter of fiscal 2023.

“We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the Company’s CEO. “Clinical subscribers ended the quarter at 45 thousand, up 23% from Q2. We are encouraged by the trends across our business and we expect to end the year with total subscribers slightly above 3.7 million, representing the best seasonal slope in the Company’s reporting history.”

“We are executing well against our strategy and are on track for meeting, and in some cases exceeding, our 2023 objectives. As anticipated, the strategic decisions to promote long-term commitment plans and to wind down our low-margin consumer products business pressured revenues in the quarter. However, as demonstrated by our record gross margin, I am confident we are making the right decisions to return the business to profitable growth,” said Heather Stark, the Company’s CFO.

Q3 2023 Consolidated Results

 

														% Change
		Three Months Ended												Adjusted for
		September 30,  2023				October 1,  2022				% Change				Constant  Currency(1)
(in millions except percentages and per share amounts)
Subscription Revenues, net			$203.5				$220.7				(7.8%)				(9.2%)
Product Sales and Other, net			11.4				29.0				(60.7%)				(61.0%)
Revenues, net			$214.9				$249.7				(14.0%)				(15.3%)
Gross Profit			$141.8				$152.4				(7.0%)				(8.7%)
Non-GAAP Adjustments(1)
Net Restructuring Charges(2)			0.4				0.0
Adjusted Gross Profit(1)			$142.2				$152.4				(6.7%)				(8.5%)
Operating Income (Loss)			$30.6				($254.5)				112.0%				111.4%
Non-GAAP Adjustments(1)
Franchise Rights Acquired Impairments			-				312.7
Net Restructuring Charges(2)			6.0				3.7
Adjusted Operating Income(1)			$36.6				$61.9				(40.9%)				(43.5%)
Net Income (Loss)			$43.7				($206.0)				100.0%*				100.0%*
EPS			$0.54				($2.93)				100.0%*				100.0%*
Total Paid Weeks			52.5				51.9				1.0%				N/A
Digital(3) Paid Weeks			42.8				41.6				2.9%				N/A
Workshops + Digital(4) Paid Weeks			9.1				10.3				(11.6%)				N/A
Clinical(5) Paid Weeks			0.5				-				N/A				N/A
End of Period Subscribers(6)			4.0				3.8				6.0%				N/A
Digital Subscribers			3.3				3.0				7.8%				N/A
Workshops + Digital Subscribers			0.7				0.7				(7.3%)				N/A
Clinical Subscribers			0.0				-				N/A				N/A

 

 

Note: Totals may not sum due to rounding.

*Note: Percentage in excess of 100.0% and not meaningful.

(1)

See “Reconciliation of Non-GAAP Financial Measures” attached to this release for further detail on adjustments to GAAP financial measures.

(2)

See “Reconciliation of Non-GAAP Financial Measures” attached to this release for further detail on the Company’s previously disclosed 2023, 2022, and 2021 restructuring plans, and the reversal of certain of the charges associated therewith.

(3)

“Digital” refers to providing subscriptions to the Company’s digital product offerings, which formerly included Digital 360 (as applicable).

(4)

“Workshops + Digital” refers to providing unlimited access to the Company’s workshops combined with the Company’s digital subscription product offerings to commitment plan subscribers, including former Digital 360 members (as applicable). It also formerly included the provision of access to workshops for members who did not subscribe to commitment plans, which included the Company’s “pay-as-you-go” members.

(5)

“Clinical” refers to providing subscriptions to the Company’s clinical product offerings included in its Sequence program.

(6)

“Subscribers” refers to Digital subscribers, Workshops + Digital subscribers, and Clinical subscribers who participate in recurring bill programs in Company-owned operations.

Q3 2023 Business and Financial Highlights

 

●

End of Period Subscribers in Q3 2023 were up 6.0% versus the prior year period, driven by the Digital business and the inclusion of 45 thousand Clinical Subscribers. Q3 2023 End of Period Digital Subscribers increased 7.8% versus the prior year period. Q3 2023 End of Period Workshops + Digital Subscribers decreased 7.3% versus the prior year period.

 

●

Total Paid Weeks in Q3 2023 were up 1.0% versus the prior year period, driven by the Digital business in North America and the inclusion of 534 thousand Clinical Paid Weeks. Q3 2023 Digital Paid Weeks increased 2.9% versus the prior year period. Q3 2023 Workshops + Digital Paid Weeks decreased 11.6% versus the prior year period.

 

●

Revenues in Q3 2023 were $214.9 million. On a constant currency basis, Q3 2023 revenues decreased 15.3% versus the prior year period.

 

¡

Subscription Revenues in Q3 2023 were $203.5 million. On a constant currency basis, these revenues decreased 9.2% versus the prior year period. Subscription Revenues included $10.0 million of Clinical Subscription Revenues.

 

¡

Product Sales and Other in Q3 2023 were $11.4 million. On a constant currency basis, these revenues decreased 61.0% versus the prior year period driven by the continued wind down of the consumer products business.

 

●

Gross Profit in Q3 2023 was $141.8 million, compared to $152.4 million in the prior year period. Adjusted gross profit in Q3 2023, which excluded the net impact of $0.4 million of restructuring charges, was $142.2 million. Adjusted gross profit in Q3 2022, which excluded the net impact of $0.0 million of restructuring charges, was $152.4 million.

 

¡

Gross Margin in Q3 2023 was 66.0%, as compared to 61.0% in the prior year period. Adjusted gross margin in Q3 2023 was 66.2%, up from an adjusted gross margin of 61.0% in the prior year period, primarily driven by actions to reduce the fixed cost base within the Workshops + Digital business and a revenue mix shift to the Company’s higher margin Digital business.

 

●

Operating Income in Q3 2023 was $30.6 million, compared to operating loss of $254.5 million in the prior year period. Adjusted operating income in Q3 2023, which excluded the net impact of $6.0 million of restructuring charges, was $36.6 million. Adjusted operating income in Q3 2022, which excluded the impact of non-cash intangible impairment charges totaling $312.7 million and the net impact of $3.7 million of restructuring charges, was $61.9 million.

 

●

Income Tax Benefit in Q3 2023 was $38.4 million, which reflected the impact of an unusually high negative annual effective tax rate driven by a valuation allowance and small pretax loss reflected in the Company’s full year fiscal 2023 guidance. In the prior year period, income tax was a benefit of $70.7 million.

 

●

Net Income in Q3 2023 was $43.7 million compared to net loss of $206.0 million in the prior year period.

●

Diluted earnings per share in Q3 2023 was $0.54 compared to diluted net loss per share of $2.93 in the prior year period.

¡

Certain items affect year-over-year comparability.

∎

Q3 2023 diluted earnings per share incorporated the net positive impact of $0.48 per diluted share in the aggregate due to the following items:

●

$0.54 per diluted share positive tax impact arising from an unusually high negative annual effective tax rate as a result of a valuation allowance and small pretax loss reflected in the Company’s full year fiscal 2023 guidance, mentioned above.

●

$0.06 per diluted share net negative impact of restructuring charges.

∎

Q3 2022 diluted net loss per share incorporated the negative impact of $3.38 per diluted share in the aggregate due to the following items:

●

$3.34 per diluted share negative impact of non-cash intangible impairment charges for Franchise Rights Acquired.

●

$0.04 per diluted share net negative impact of restructuring charges.

Other Items

●

Cash balance as of September 30, 2023 was $107.5 million. On that same date, the Company had no outstanding borrowings under its revolving credit facility.

●

2023 Restructuring Plan: In connection with the previously announced 2023 restructuring plan, the Company recorded aggregate restructuring charges of $6.2 million in Q3 2023. The Company anticipates recording restructuring charges of up to $10.0 million in Q4 2023, increasing the Company’s estimated range for the 2023 restructuring plan to be between $47.0 million to $54.0 million.

Full Year Fiscal 2023 Guidance

The Company is updating its full year fiscal 2023 guidance:

 

●

Revenues are expected to be at the low end of the previously provided range of $890.0 million to $910.0 million.

●

Operating income is now expected to be in the range of $31.0 million to $43.0 million, compared to the previously provided range of $39.0 million to $51.0 million, due to increased anticipated restructuring charges. Adjusted operating income, which excludes the net impact of restructuring charges and acquisition transaction costs, is still expected to be towards the high end of the previously provided range of $80.0 million to $85.0 million.

Third Quarter 2023 Conference Call and Webcast

The Company has scheduled a conference call today at 4:30 p.m. ET. During the conference call, Sima Sistani, Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter of fiscal 2023 results and answer questions from the investment community.

The live webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com, in the Investors section under Presentations and Events. Supplemental investor materials will also be available in the same location prior to the start of the webcast. A replay of the webcast will be available on this site for approximately 90 days.

Statement regarding Non-GAAP Financial Measures

The following provides information regarding non-GAAP financial measures used in this earnings release and today’s scheduled conference call:

To supplement the Company’s consolidated results presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company has disclosed non-GAAP financial measures of operating results that exclude or adjust certain items. Gross profit, gross margin, operating income (loss), operating income (loss) margin, and selling, general and administrative expenses are discussed both as reported (on a GAAP basis) and as adjusted (on a non-GAAP basis), as applicable, with respect to (i) the third quarter of fiscal 2023 to exclude the net impact of (a) charges associated with the Company’s previously disclosed 2023 restructuring plan (the “2023 plan”) and (b) the reversal of certain of the charges associated with the Company’s previously disclosed 2022 restructuring plan (the “2022 plan”); (ii) the first nine months of fiscal 2023 to exclude (a) the net impact of (w) charges associated with the 2023 plan, (x) charges associated with the 2022 plan or the reversal of certain of the charges associated with the 2022 plan, as applicable, (y) charges associated with the Company’s previously disclosed 2021 organizational restructuring plan (the “2021 plan”) or the reversal of certain of the charges associated with the 2021 plan, as applicable, and (z) the reversal of certain of the charges associated with the Company’s previously disclosed 2020 organizational restructuring plan (the “2020 plan”) and (b) the impact of certain non-recurring transaction costs in connection with the acquisition of Sequence (as defined below); (iii) the third quarter of fiscal 2022 to exclude (a) the impact of impairment charges for the Company’s franchise rights acquired related to its United States, Canada and New Zealand units of account and (b) the net impact of (x) charges associated with the 2022 plan and (y) charges associated with the 2021 plan; and (iv) the first nine months of fiscal 2022 to exclude (a) the impact of impairment charges for the Company’s franchise rights acquired related to its United States, Canada and New Zealand units of account and the impairment charge for the Company’s goodwill related to its wholly-owned subsidiary Kurbo, Inc. (“Kurbo”) and (b) the net impact of (x) charges associated with the 2022 plan, (y) charges associated with the 2021 plan or the reversal of certain of the charges associated with the 2021 plan, as applicable, and (z) the reversal of certain of the charges associated with the 2020 plan. We generally refer to such non-GAAP measures as follows: (i) with respect to the adjustments for the third quarter of fiscal 2023, as excluding or adjusting for the net impact of restructuring charges; (ii) with respect to the adjustments for the first nine months of fiscal 2023, as excluding or adjusting for the net impact of restructuring charges and the impact of acquisition transaction costs; (iii) with respect to the adjustments for the third quarter of fiscal 2022, as excluding or adjusting for the impact of the franchise rights acquired impairments and the net impact of restructuring charges; and (iv) with respect to the adjustments for the first nine months of fiscal 2022, as excluding or adjusting for the impact of franchise rights acquired and goodwill impairments and the net impact of restructuring charges. The Company also presents in the attachments to this release the non-GAAP financial measures earnings before interest, taxes, depreciation, amortization and stock-based compensation (“EBITDAS”); earnings before interest, taxes, depreciation, amortization, stock-based compensation, franchise rights acquired and goodwill impairments, net restructuring charges, and certain non-recurring transaction costs in connection with the acquisition of Sequence (“Adjusted EBITDAS”); total debt less unamortized deferred financing costs, unamortized debt discount and cash on hand (i.e., net debt); and a net debt/Adjusted EBITDAS ratio. Adjusted EBITDAS for the first quarter of fiscal 2023 as presented herein was recast to reflect certain non-recurring

transaction costs in connection with the acquisition of Sequence. In addition, the Company presents certain of its financial results on a constant currency basis in addition to GAAP results. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. The Company calculates constant currency by calculating current-year results using prior-year foreign currency exchange rates.

Management believes these non-GAAP financial measures provide useful supplemental information for its and investors’ evaluation of the Company’s business performance and are useful for period-over-period comparisons of the performance of the Company’s business. While management believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similarly entitled measures reported by other companies. See “Reconciliation of Non-GAAP Financial Measures” attached to this release and reconciliations, if any, included elsewhere in this release for a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures.

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management program. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our program. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

This news release and any attachments include “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, in particular, any guidance and any statements about the Company’s plans, strategies, objectives, initiatives, roadmap and prospects. The Company generally uses the words “may,” “will,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “aim” and similar expressions in this news release and any attachments to identify forward-looking statements. The Company bases these forward-looking statements on its current views with respect to future events and financial performance. Actual results could differ materially from those projected in the forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions, including, among other things: the impact of the COVID-19 pandemic on the Company’s business and on the consumer environment and markets in which the Company operates; competition from other weight management and wellness industry participants or the development of more effective or more favorably perceived weight management methods; the Company’s failure to continue to retain and grow its subscriber base; the Company’s ability to continue to develop new, innovative services and products and enhance its existing services and products or the failure of its services, products or brands to continue to appeal to the market, or its ability to successfully expand into new channels of distribution or respond to consumer trends or sentiment; the ability to successfully implement strategic initiatives; the Company’s ability to transform its Workshops + Digital business strategy to meet the evolving needs of its members; the effectiveness and efficiency of the Company’s advertising and marketing programs, including the strength of the Company’s social media presence; the impact on the Company’s reputation of actions taken by its franchisees, licensees, suppliers and other partners, including as a result of its acquisition of Weekend Health, Inc., which is doing business as Sequence (“Sequence”) (the “Acquisition”); the recognition of asset impairment charges; the loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate the Company’s workforce; the Company’s chief executive officer transition; the inability to renew certain of the Company’s licenses, or the inability to do so on terms that are favorable to the Company; the early termination by the Company of leases; uncertainties related to a downturn in general economic conditions or consumer confidence, including as a result of the existing inflationary environment, the potential impact of political and social unrest and instability in the banking system as a result of several

recent bank failures; the Company’s ability to successfully make acquisitions or enter into joint ventures or collaborations, including its ability to successfully integrate, operate or realize the anticipated benefits of such businesses, including with respect to Sequence; the seasonal nature of the Company’s principal business; the impact of events that discourage or impede people from gathering with others or impede accessing resources; the Company’s failure to maintain effective internal control over financial reporting; the impact of the Company’s substantial amount of debt, debt service obligations and debt covenants, and its exposure to variable rate indebtedness; the ability to generate sufficient cash to service the Company’s debt and satisfy its other liquidity requirements; uncertainties regarding the satisfactory operation of the Company’s technology or systems; the impact of data security breaches and other malicious acts or privacy concerns, including the costs of compliance with evolving privacy laws and regulations; the Company’s ability to enforce its intellectual property rights both domestically and internationally, as well as the impact of its involvement in any claims related to intellectual property rights; risks and uncertainties associated with the Company’s international operations, including regulatory, economic, political, social, intellectual property, and foreign currency risks, which risks may be exacerbated as a result of war and terrorism; the outcomes of litigation or regulatory actions; the impact of existing and future laws and regulations; risks related to the Company’s Acquisition, including risks that the Acquisition may not achieve its intended results; risks related to the Company’s exposure to extensive and complex healthcare laws and regulations as a result of the Acquisition; the impact that the sale of substantial amounts of the Company’s common stock by existing large shareholders, or the perception that such sales could occur, could have on the market price of the Company’s common stock; and other risks and uncertainties, including those detailed from time to time in the Company’s periodic reports filed with the United States Securities and Exchange Commission (the “SEC”) (which are available on the SEC’s EDGAR database at www.sec.gov and via the Company’s website at corporate.ww.com). You should not put undue reliance on any forward-looking statements. You should understand that many important factors, including those discussed herein, could cause the Company’s results to differ materially from those expressed or suggested in any forward-looking statement. Except as required by law, the Company does not undertake any obligation to update or revise these forward-looking statements to reflect new information or events or circumstances that occur after the date of this news release or to reflect the occurrence of unanticipated events or otherwise. Readers are advised to review the Company’s filings with the SEC (which are available on the SEC’s EDGAR database at www.sec.gov and via the Company’s website at corporate.ww.com).

WW INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS AT

(IN THOUSANDS)

UNAUDITED

 

		September 30,   2023				December 31,   2022
ASSETS
CURRENT ASSETS
Cash and cash equivalents		$	107,498			$	178,326
Receivables (net of allowances: September 30, 2023 - $1,435 and December 31, 2022 - $976)			19,178				24,273
Inventories			10,141				20,528
Prepaid income taxes			53,880				19,447
Prepaid expenses and other current assets			28,092				38,757
TOTAL CURRENT ASSETS			218,789				281,331
Property and equipment, net			22,608				28,229
Operating lease assets			55,414				75,696
Franchise rights acquired			386,168				386,745
Goodwill			244,927				155,998
Other intangible assets, net			66,532				63,306
Deferred income taxes			20,728				22,246
Other noncurrent assets			17,087				14,879
TOTAL ASSETS		$	1,032,253			$	1,028,430
LIABILITIES AND TOTAL DEFICIT
CURRENT LIABILITIES
Portion of operating lease liabilities due within one year		$	9,804			$	17,955
Accounts payable			19,732				18,890
Salaries and wages payable			61,794				72,577
Accrued marketing and advertising			13,645				17,927
Accrued interest			10,969				5,289
Other accrued liabilities			44,569				30,118
Income taxes payable			987				1,646
Deferred revenue			32,445				32,156
TOTAL CURRENT LIABILITIES			193,945				196,558
Long-term debt, net			1,425,419				1,422,284
Long-term operating lease liabilities			56,643				68,099
Deferred income taxes			15,932				25,084			(1)
Other			15,481				2,185
TOTAL LIABILITIES			1,707,420				1,714,210			(1)
TOTAL DEFICIT
Common stock, $0 par value; 1,000,000 shares authorized; 130,048 shares issued at September 30, 2023 and 122,052 shares issued at December 31, 2022			0				0
Treasury stock, at cost, 51,030 shares at September 30, 2023 and 51,496 shares at December 31, 2022			(3,073,196	)			(3,097,304	)
Retained earnings			2,409,997				2,416,994			(1)
Accumulated other comprehensive loss			(11,968	)			(5,470	)
TOTAL DEFICIT			(675,167	)			(685,780	)		(1)
TOTAL LIABILITIES AND TOTAL DEFICIT		$	1,032,253			$	1,028,430

 

 

⁽¹⁾ Certain amounts have been revised at December 31, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company’s Form 10-Q filing for the fiscal quarter ended September 30, 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

UNAUDITED

 

		Three Months Ended
		September 30,  2023				October 1,  2022
Subscription revenues, net (1)		$	203,496			$	220,746
Product sales and other, net (2)			11,375				28,972
Revenues, net			214,871				249,718
Cost of subscription revenues (3)			67,080				73,541
Cost of product sales and other			6,036				23,826
Cost of revenues			73,116				97,367
Gross profit			141,755				152,351
Marketing expenses			48,114				35,696
Selling, general and administrative expenses			63,034				58,443
Franchise rights acquired impairments			—				312,741
Operating income (loss)			30,607				(254,529	)
Interest expense			24,508				20,912
Other expense, net			815				1,344
Income (loss) before income taxes			5,284				(276,785	)
Benefit from income taxes			(38,447	)			(70,749	)
Net income (loss)		$	43,731			$	(206,036	)
Earnings (net loss) per share
Basic		$	0.55			$	(2.93	)
Diluted		$	0.54			$	(2.93	)
Weighted average common shares outstanding
Basic			78,979				70,383
Diluted			80,638				70,383

 

 

 Note: Totals may not sum due to rounding.

⁽¹⁾ Consists of net “Digital Subscription Revenues”, net “Workshops + Digital Fees” and net “Clinical Subscription Revenues”. “Digital Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Digital offerings, which formerly included Digital 360 (as applicable). “Workshops + Digital Fees” consist of the fees associated with the Company’s subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops. “Clinical Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Clinical offerings.

⁽²⁾ Consists of sales of consumer products via e-commerce, in studios and through the Company’s trusted partners, revenues from licensing and publishing, other revenues, and franchise fees with respect to commitment plans and royalties.

⁽³⁾ Consists of cost of revenues and operating expenses for the Company’s Digital, Workshops + Digital and Clinical services. 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

UNAUDITED

 

		Nine Months Ended
		September 30,  2023				October 1,  2022
Subscription revenues, net (1)		$	626,667			$	718,122
Product sales and other, net (2)			56,927				98,810
Revenues, net			683,594				816,932
Cost of subscription revenues (3)			233,354				243,710
Cost of product sales and other			45,794				77,811
Cost of revenues			279,148				321,521
Gross profit			404,446				495,411
Marketing expenses			187,468				195,123
Selling, general and administrative expenses			188,638				193,320
Franchise rights acquired and goodwill impairments			—				339,161
Operating income (loss)			28,340				(232,193	)
Interest expense			71,429				58,837
Other (income) expense, net			(36	)			3,303
Loss before income taxes			(43,053	)			(294,333	)
Benefit from income taxes			(18,933	)			(73,246	)		(4)
Net loss		$	(24,120	)		$	(221,087	)		(4)
Net loss per share
Basic		$	(0.32	)		$	(3.15	)		(4)
Diluted		$	(0.32	)		$	(3.15	)		(4)
Weighted average common shares outstanding
Basic			75,861				70,258
Diluted			75,861				70,258

 

 

 Note: Totals may not sum due to rounding.

⁽¹⁾ Consists of net “Digital Subscription Revenues”, net “Workshops + Digital Fees” and net “Clinical Subscription Revenues”. “Digital Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Digital offerings, which formerly included Digital 360 (as applicable). “Workshops + Digital Fees” consist of the fees associated with the Company’s subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops. “Clinical Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Clinical offerings.

⁽²⁾ Consists of sales of consumer products via e-commerce, in studios and through the Company’s trusted partners, revenues from licensing and publishing, other revenues, and franchise fees with respect to commitment plans and royalties.

⁽³⁾ Consists of cost of revenues and operating expenses for the Company’s Digital, Workshops + Digital and Clinical services.

⁽⁴⁾ Certain amounts have been revised for the nine months ended October 1, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company’s Form 10-Q filing for the fiscal quarter ended September 30, 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

UNAUDITED

 

		Nine Months Ended
		September 30, 2023						October 1, 2022
Operating activities:
Net loss		$	(24,120	)				$	(221,087	)		(1)
Adjustments to reconcile net loss to cash (used for) provided by operating activities:
Depreciation and amortization			39,805						33,371
Amortization of deferred financing costs and debt discount			3,763						3,763
Impairment of franchise rights acquired and goodwill			—						339,161
Impairment of intangible and long-lived assets			197						2,088
Share-based compensation expense			12,838						10,362
Deferred tax benefit			(7,449	)					(107,879	)
Allowance for doubtful accounts			407						54
Reserve for inventory obsolescence			1,897						4,712
Foreign currency exchange rate (gain) loss			(31	)					3,562
Changes in cash due to:
Receivables			9,117						(9,760	)
Inventories			9,009						(725	)
Prepaid expenses			(27,301	)					17,613
Accounts payable			1,221						(3,634	)
Accrued liabilities			(17,010	)					15,390
Deferred revenue			309						(3,576	)
Other long term assets and liabilities, net			(2,701	)					(4,662	)
Income taxes			(1,104	)					1,793			(1)
Cash (used for) provided by operating activities			(1,153	)					80,546
Investing activities:
Capital expenditures			(2,143	)					(1,756	)
Capitalized software expenditures			(26,190	)					(27,584	)
Cash paid for acquisitions, net of cash acquired			(38,362	)					(4,350	)
Other items, net			(14	)					(29	)
Cash used for investing activities			(66,709	)					(33,719	)
Financing activities:
Taxes paid related to net share settlement of equity awards			(1,417	)					(1,938	)
Proceeds from stock options exercised			710						—
Cash paid for acquisitions			(1,178	)					(113	)
Other items, net			(43	)					(86	)
Cash used for financing activities			(1,928	)					(2,137	)
Effect of exchange rate changes on cash and cash equivalents			(1,038	)					(10,193	)
Net (decrease) increase in cash and cash equivalents			(70,828	)					34,497
Cash and cash equivalents, beginning of period			178,326						153,794
Cash and cash equivalents, end of period		$	107,498					$	188,291

 

 

⁽¹⁾ Certain amounts have been revised for the nine months ended October 1, 2022 to correct immaterial errors related to certain tax matters, which will be more fully described in the Company’s Form 10-Q filing for the fiscal quarter ended September 30, 2023.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

OPERATIONAL STATISTICS

(IN THOUSANDS, EXCEPT PERCENTAGES)

UNAUDITED

 

		Three Months Ended
		September 30,				October 1,				Variance
		2023				2022
Digital Paid Weeks (1)
North America			27,605				26,274				5.1%
International			15,205				15,325				(0.8%)
Total Digital Paid Weeks			42,810				41,599				2.9%
Workshops + Digital Paid Weeks (1)
North America			6,882				7,753				(11.2%)
International			2,251				2,581				(12.8%)
Total Workshops + Digital Paid Weeks			9,133				10,334				(11.6%)
Clinical Paid Weeks (1)
North America			534				—				N/A
International			—				—				—
Total Clinical Paid Weeks			534				—				N/A
Total Paid Weeks (1)
North America			35,021				34,028				2.9%
International			17,457				17,905				(2.5%)
Total Paid Weeks			52,478				51,933				1.0%
End of Period Digital Subscribers (2)
North America			2,112				1,908				10.7%
International			1,172				1,138				3.0%
Total End of Period Digital Subscribers			3,284				3,046				7.8%
End of Period Workshops + Digital Subscribers (2)
North America			518				555				(6.7%)
International			175				192				(9.2%)
Total End of Period Workshops + Digital Subscribers			693				748				(7.3%)
End of Period Clinical Subscribers (2)
North America			45				—				N/A
International			—				—				—
Total End of Period Clinical Subscribers			45				—				N/A
Total End of Period Subscribers (2)
North America			2,676				2,464				8.6%
International			1,346				1,330				1.2%
Total End of Period Subscribers			4,022				3,794				6.0%

 

 

 Note: Totals may not sum due to rounding. 

⁽¹⁾ The “Paid Weeks” metric reports paid weeks by WW customers in Company-owned operations for a given period as follows: (i) “Digital Paid Weeks” is the total paid subscription weeks for the Company’s digital subscription products, which formerly included Digital 360 (as applicable); (ii) “Workshops + Digital Paid Weeks” is the sum of total paid commitment plan weeks which include workshops and digital offerings and formerly included total “pay-as-you-go” weeks; (iii) “Clinical Paid Weeks” is the total paid subscription weeks for the Company’s Clinical subscription products; and (iv) “Total Paid Weeks” is the sum of Digital Paid Weeks, Workshops + Digital Paid Weeks and Clinical Paid Weeks.

⁽²⁾ The “End of Period Subscribers” metric reports WW subscribers in Company-owned operations at a given period end as follows: (i) “End of Period Digital Subscribers” is the total number of Digital, including former Digital 360 (as applicable), subscribers; (ii) “End of Period Workshops + Digital Subscribers” is the total number of commitment plan subscribers that have access to combined workshops and digital offerings; (iii) “End of Period Clinical Subscribers” is the total number of Clinical subscribers; and (iv) “End of Period Subscribers” is the sum of End of Period Digital Subscribers, End of Period Workshops + Digital Subscribers and End of Period Clinical Subscribers.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

OPERATIONAL STATISTICS

(IN THOUSANDS, EXCEPT PERCENTAGES)

UNAUDITED

 

		Nine Months Ended
		September 30, 2023				October 1, 2022				Variance
Digital Paid Weeks (1)
North America			81,392				87,743				(7.2%)
International			45,465				50,312				(9.6%)
Total Digital Paid Weeks			126,858				138,055				(8.1%)
Workshops + Digital Paid Weeks (1)
North America			21,914				22,724				(3.6%)
International			7,126				7,547				(5.6%)
Total Workshops + Digital Paid Weeks			29,039				30,271				(4.1%)
Clinical Paid Weeks (1)
North America			889				—				N/A
International			—				—				—
Total Clinical Paid Weeks			889				—				N/A
Total Paid Weeks (1)
North America			104,195				110,466				(5.7%)
International			52,591				57,860				(9.1%)
Total Paid Weeks			156,786				168,326				(6.9%)
End of Period Digital Subscribers (2)
North America			2,112				1,908				10.7%
International			1,172				1,138				3.0%
Total End of Period Digital Subscribers			3,284				3,046				7.8%
End of Period Workshops + Digital Subscribers (2)
North America			518				555				(6.7%)
International			175				192				(9.2%)
Total End of Period Workshops + Digital Subscribers			693				748				(7.3%)
End of Period Clinical Subscribers (2)
North America			45				—				N/A
International			—				—				—
Total End of Period Clinical Subscribers			45				—				N/A
Total End of Period Subscribers (2)
North America			2,676				2,464				8.6%
International			1,346				1,330				1.2%
Total End of Period Subscribers			4,022				3,794				6.0%

 

 

 Note: Totals may not sum due to rounding.

⁽¹⁾ The “Paid Weeks” metric reports paid weeks by WW customers in Company-owned operations for a given period as follows: (i) “Digital Paid Weeks” is the total paid subscription weeks for the Company’s digital subscription products, which formerly included Digital 360 (as applicable); (ii) “Workshops + Digital Paid Weeks” is the sum of total paid commitment plan weeks which include workshops and digital offerings and formerly included total “pay-as-you-go” weeks; (iii) “Clinical Paid Weeks” is the total paid subscription weeks for the Company’s Clinical subscription products; and (iv) “Total Paid Weeks” is the sum of Digital Paid Weeks, Workshops + Digital Paid Weeks and Clinical Paid Weeks.

⁽²⁾ The “End of Period Subscribers” metric reports WW subscribers in Company-owned operations at a given period end as follows: (i) “End of Period Digital Subscribers” is the total number of Digital, including former Digital 360 (as applicable), subscribers; (ii) “End of Period Workshops + Digital Subscribers” is the total number of commitment plan subscribers that have access to combined workshops and digital offerings; (iii) “End of Period Clinical Subscribers” is the total number of Clinical subscribers; and (iv) “End of Period Subscribers” is the sum of End of Period Digital Subscribers, End of Period Workshops + Digital Subscribers and End of Period Clinical Subscribers.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(IN THOUSANDS, EXCEPT PERCENTAGES)

UNAUDITED

 

																		Q3 2023 Variance
																						2023
																						Constant
		Q3 2023												Q3 2022				2023				Currency
						Currency				Constant								vs				vs
		GAAP				Adjustment				Currency				GAAP				2022				2022
Selected Financial Data
Consolidated Company Revenues		$	214,871			$	(3,246	)		$	211,625			$	249,718				(14.0%)				(15.3%)
Consolidated Digital Subscription Revenues (1)		$	140,889			$	(2,671	)		$	138,218			$	155,881				(9.6%)				(11.3%)
Consolidated Workshops + Digital Fees (2)		$	52,618			$	(491	)		$	52,127			$	64,865				(18.9%)				(19.6%)
Consolidated Clinical Subscription Revenues (3)		$	9,989			$	—			$	9,989			$	—				N/A				N/A
Consolidated Subscription Revenues (4)		$	203,496			$	(3,161	)		$	200,335			$	220,746				(7.8%)				(9.2%)
Consolidated Product Sales and Other (5)		$	11,375			$	(85	)		$	11,290			$	28,972				(60.7%)				(61.0%)
North America
Digital Subscription Revenues (1)		$	92,437			$	151			$	92,588			$	102,735				(10.0%)				(9.9%)
Workshops + Digital Fees (2)		$	42,867			$	54			$	42,921			$	52,113				(17.7%)				(17.6%)
Clinical Subscription Revenues (3)		$	9,989			$	—			$	9,989			$	—				N/A				N/A
Subscription Revenues (4)		$	145,293			$	205			$	145,498			$	154,848				(6.2%)				(6.0%)
Product Sales and Other (5)		$	9,394			$	5			$	9,399			$	21,621				(56.6%)				(56.5%)
Total Revenues		$	154,687			$	210			$	154,897			$	176,469				(12.3%)				(12.2%)
International
Digital Subscription Revenues (1)		$	48,452			$	(2,821	)		$	45,631			$	53,146				(8.8%)				(14.1%)
Workshops + Digital Fees (2)		$	9,751			$	(545	)		$	9,206			$	12,752				(23.5%)				(27.8%)
Clinical Subscription Revenues (3)		$	—			$	—			$	—			$	—				N/A				N/A
Subscription Revenues (4)		$	58,203			$	(3,366	)		$	54,837			$	65,898				(11.7%)				(16.8%)
Product Sales and Other (5)		$	1,981			$	(90	)		$	1,891			$	7,351				(73.1%)				(74.3%)
Total Revenues		$	60,184			$	(3,456	)		$	56,728			$	73,249				(17.8%)				(22.6%)

 

 

 Note: Totals may not sum due to rounding.

⁽¹⁾ “Digital Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Digital offerings, which formerly included Digital 360 (as applicable).

⁽²⁾ “Workshops + Digital Fees” consist of the fees associated with the Company’s subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops.

⁽³⁾ “Clinical Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Clinical offerings.

⁽⁴⁾ “Subscription Revenues” equal “Digital Subscription Revenues” plus “Workshops + Digital Fees” plus “Clinical Subscription Revenues”.

⁽⁵⁾ “Product Sales and Other” are sales of consumer products via e-commerce, in studios and through the Company’s trusted partners, revenues from licensing and publishing, other revenues, and, in the case of the consolidated financial results and North America reportable segment, franchise fees with respect to commitment plans and royalties.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(IN THOUSANDS, EXCEPT PERCENTAGES)

UNAUDITED

 

																		YTD 2023 Variance
																						2023
																						Constant
		YTD 2023												YTD 2022				2023				Currency
						Currency				Constant								vs				vs
		GAAP				Adjustment				Currency				GAAP				2022				2022
Selected Financial Data
Consolidated Company Revenues		$	683,594			$	1,696			$	685,290			$	816,932				(16.3%)				(16.1%)
Consolidated Digital Subscription Revenues (1)		$	437,613			$	610			$	438,223			$	521,582				(16.1%)				(16.0%)
Consolidated Workshops + Digital Fees (2)		$	171,473			$	601			$	172,074			$	196,540				(12.8%)				(12.4%)
Consolidated Clinical Subscription Revenues (3)		$	17,581			$	—			$	17,581			$	—				N/A				N/A
Consolidated Subscription Revenues (4)		$	626,667			$	1,211			$	627,878			$	718,122				(12.7%)				(12.6%)
Consolidated Product Sales and Other (5)		$	56,927			$	485			$	57,412			$	98,810				(42.4%)				(41.9%)
North America
Digital Subscription Revenues (1)		$	285,655			$	878			$	286,533			$	342,489				(16.6%)				(16.3%)
Workshops + Digital Fees (2)		$	138,639			$	326			$	138,965			$	155,558				(10.9%)				(10.7%)
Clinical Subscription Revenues (3)		$	17,581			$	—			$	17,581			$	—				N/A				N/A
Subscription Revenues (4)		$	441,875			$	1,204			$	443,079			$	498,047				(11.3%)				(11.0%)
Product Sales and Other (5)		$	46,025			$	116			$	46,141			$	71,478				(35.6%)				(35.4%)
Total Revenues		$	487,900			$	1,320			$	489,220			$	569,525				(14.3%)				(14.1%)
International
Digital Subscription Revenues (1)		$	151,958			$	(268	)		$	151,690			$	179,093				(15.2%)				(15.3%)
Workshops + Digital Fees (2)		$	32,834			$	276			$	33,110			$	40,982				(19.9%)				(19.2%)
Clinical Subscription Revenues (3)		$	—			$	—			$	—			$	—				N/A				N/A
Subscription Revenues (4)		$	184,792			$	7			$	184,799			$	220,075				(16.0%)				(16.0%)
Product Sales and Other (5)		$	10,902			$	369			$	11,271			$	27,332				(60.1%)				(58.8%)
Total Revenues		$	195,694			$	376			$	196,070			$	247,407				(20.9%)				(20.8%)

 

 

 Note: Totals may not sum due to rounding.

⁽¹⁾ “Digital Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Digital offerings, which formerly included Digital 360 (as applicable).

⁽²⁾ “Workshops + Digital Fees” consist of the fees associated with the Company’s subscription plans for combined workshops and digital offerings and other payment arrangements for access to workshops.

⁽³⁾ “Clinical Subscription Revenues” consist of the fees associated with subscriptions for the Company’s Clinical offerings.

⁽⁴⁾ “Subscription Revenues” equal “Digital Subscription Revenues” plus “Workshops + Digital Fees” plus “Clinical Subscription Revenues”.

⁽⁵⁾ “Product Sales and Other” are sales of consumer products via e-commerce, in studios and through the Company’s trusted partners, revenues from licensing and publishing, other revenues, and, in the case of the consolidated financial results and North America reportable segment, franchise fees with respect to commitment plans and royalties.

WW INTERNATIONAL, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(IN THOUSANDS, EXCEPT PERCENTAGES)

UNAUDITED

 

																																										Q3 2023 Variance
																																																		2023 Constant Currency
																																														2023								2023
		Q3 2023																										Q3 2022																		Adjusted								Adjusted
																								Adjusted																		2023				vs				2023				vs
																Currency				Constant				Constant																		vs				2022				vs				2022
		GAAP				Adjustment						Adjusted				Adjustment				Currency				Currency				GAAP				Adjustment						Adjusted				2022				Adjusted				2022				Adjusted
Selected Financial Data
Gross Profit		$	141,755			$	398			(1)		$	142,153			$	(2,672)			$	139,083			$	139,481			$	152,351			$	6			(4)		$	152,357				(7.0%)				(6.7%)				(8.7%)				(8.5%)
Gross Margin			66.0%										66.2%								65.7%				65.9%				61.0%										61.0%
Selling, General and Administrative Expenses		$	63,034			$	(5,577	)		(2)		$	57,457			$	(485)			$	62,549			$	56,972			$	58,443			$	(3,654	)		(5)		$	54,789				7.9%				4.9%				7.0%				4.0%
Operating Income (Loss)		$	30,607			$	5,975			(3)		$	36,582			$	(1,598)			$	29,009			$	34,984			$	(254,529	)		$	316,401			(6)		$	61,872				112.0%				(40.9%)				111.4%				(43.5%)
Operating Income (Loss) Margin			14.2%										17.0%								13.7%				16.5%				(101.9%	)									24.8%

 

 

 Note: Totals may not sum due to rounding.

 

(1)

Excludes the net impact of $444 of charges associated with the Company’s previously disclosed 2023 restructuring plan and the reversal of $46 of charges associated with the Company’s previously disclosed 2022 restructuring plan.

 

(2)

Excludes the net impact of $5,743 of charges associated with the Company’s previously disclosed 2023 restructuring plan and the reversal of $166 of charges associated with the Company’s previously disclosed 2022 restructuring plan.

 

(3)

Excludes the net impact of (x) $444 of charges and $5,743 of charges associated with the Company’s previously disclosed 2023 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, and (y) the reversal of $46 of charges and the reversal of $166 of charges associated with the Company’s previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively.

 

(4)

Excludes the net impact of the reversal of $98 of charges associated with the Company’s previously disclosed 2022 restructuring plan and $104 of charges associated with the Company’s previously disclosed 2021 organizational restructuring plan.

 

(5)

Excludes the net impact of $3,655 of charges associated with the Company’s previously disclosed 2022 restructuring plan and the reversal of $1 of charges associated with the Company’s previously disclosed 2021 organizational restructuring plan.

 

(6)

Excludes (i) the impact of impairment charges of the Company’s franchise rights acquired of $298,291, $13,312 and $1,138 related to its United States, Canada and New Zealand operations, respectively and (ii) the net impact of (x) the reversal of $98 of charges and $3,655 of charges associated with the Company’s previously disclosed 2022 restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively, and (y) $104 of charges and the reversal of $1 of charges associated with the Company’s previously disclosed 2021 organizational restructuring plan recorded to cost of subscription revenues and selling, general and administrative expenses, respectively.